Chase AIPricingFAQs
Display currency
Loading news…

Kamau Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
South San Francisco, California, United States Founded 2023 1-10 employees For Profit

Kamau Therapeutics is a clinical-stage company developing a new class of therapies to cure a range of serious and life-threatening diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
0
1 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
Patents granted
0
Trademarks
1
Top patent class
Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering

Company Info

Founded
2023
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
3
News articles
4
HQ
South San Francisco, California, United States
Region
San Francisco Bay Area, West Coast, Western US

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.4
Trend (90d)
-1.4

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Kamau Therapeutics

Loading news…

FAQs about Kamau Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Kamau Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments